SUPPRESSA, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 5.082
AS - Asia 2.312
EU - Europa 1.813
SA - Sud America 648
AF - Africa 100
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.958
Nazione #
US - Stati Uniti d'America 4.986
SG - Singapore 1.061
BR - Brasile 564
CN - Cina 497
RU - Federazione Russa 358
HK - Hong Kong 339
IT - Italia 309
SE - Svezia 284
DE - Germania 266
VN - Vietnam 167
GB - Regno Unito 127
FI - Finlandia 102
UA - Ucraina 93
FR - Francia 76
IN - India 61
CA - Canada 50
CI - Costa d'Avorio 46
NL - Olanda 45
ID - Indonesia 43
MX - Messico 29
AR - Argentina 28
BE - Belgio 26
BD - Bangladesh 25
AT - Austria 24
JP - Giappone 23
ZA - Sudafrica 23
ES - Italia 19
IE - Irlanda 16
PL - Polonia 15
CL - Cile 14
LT - Lituania 14
TR - Turchia 14
CZ - Repubblica Ceca 13
IQ - Iraq 13
CO - Colombia 11
PK - Pakistan 10
EC - Ecuador 8
MA - Marocco 8
NP - Nepal 8
SA - Arabia Saudita 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
PY - Paraguay 5
UY - Uruguay 5
UZ - Uzbekistan 5
BY - Bielorussia 4
EG - Egitto 4
JM - Giamaica 4
JO - Giordania 4
TN - Tunisia 4
AZ - Azerbaigian 3
BB - Barbados 3
BO - Bolivia 3
DK - Danimarca 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
MY - Malesia 3
PE - Perù 3
TT - Trinidad e Tobago 3
AU - Australia 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
LV - Lettonia 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SN - Senegal 2
TH - Thailandia 2
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 9.957
Città #
Ashburn 615
Fairfield 553
Singapore 506
Chandler 484
Woodbridge 368
Hong Kong 339
Seattle 222
Nyköping 219
Houston 218
Jacksonville 215
Cambridge 191
Wilmington 174
Beijing 160
Ann Arbor 141
New York 107
Lawrence 87
Roxbury 84
Dallas 83
Los Angeles 74
Nanjing 58
Munich 57
Bari 55
Des Moines 53
Abidjan 46
Boardman 46
Ho Chi Minh City 45
Dearborn 42
Santa Clara 41
Helsinki 40
São Paulo 40
Brooklyn 39
Jakarta 35
Princeton 35
Inglewood 34
Dong Ket 31
Buffalo 29
London 29
Hanoi 28
Nanchang 27
Ostuni 25
Brussels 24
Nuremberg 24
Frankfurt am Main 23
Moscow 23
Paris 23
San Diego 23
Rio de Janeiro 21
Hebei 19
Shenyang 19
Tokyo 19
Napoli 18
Toronto 17
Belo Horizonte 16
Denver 16
Dublin 16
The Dalles 15
Amsterdam 14
Johannesburg 14
Columbus 13
Jiaxing 13
Milan 13
Pune 13
Salvador 13
San Francisco 13
Shanghai 13
Changsha 12
Chennai 12
Kunming 12
Montreal 12
Taranto 12
Tianjin 11
Chicago 10
Curitiba 10
Guangzhou 10
Phoenix 10
Atlanta 9
Redwood City 9
Turku 9
Vienna 9
Washington 9
Boston 8
Campinas 8
Catania 8
Guarulhos 8
Haiphong 8
Hefei 8
Manchester 8
Mexico City 8
Mumbai 8
Poplar 8
Rome 8
Warsaw 8
Ankara 7
Brno 7
Council Bluffs 7
Falkenstein 7
Grafing 7
Hyderabad 7
Iztacalco 7
Porto Alegre 7
Totale 6.418
Nome #
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 192
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 176
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 176
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 167
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 165
Asymptomatic microhematuria: an indication of hereditary hemorrhagic telangiectasia? 160
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 155
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 153
Real-world efficacy and safety of Inclisiran: a prospective cohort study 151
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 151
Capillaroscopy of the dorsal skin of the hands in hereditary hemorrhagic telangiectasia 150
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 149
A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage 148
Biliary Cystadenoma in a Female Patient with HCV-Related Liver Cirrhosis: A Case Report 146
"A secret agent" for HHT: asyntomatyc microhematuria 144
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 140
Congenital analbuminemia in a patient affected by hypercholesterolemia: A case report 138
HHT: a rare disease with broad spectrum of clinical aspects 137
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 137
Relationship between carotid intima-media thickness and non valvular atrial fibrillation type 136
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 136
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 130
A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: A questionnaire-based retrospective study 129
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 123
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 122
"A secret Weapon" for diagnosis of HHT: the echo-color-Doppler study of the liver 121
The clinical labyrinth of chronic granulomatous diseases: not only sarcoidosis 121
Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children. 118
Low dose intravenous bevacizumab for the treatment of anaemia in hereditary haemorrhagic telangiectasia. 115
Hepatic angiodynamic profile in paediatric patients with hereditary haemorrhagic telangiectasia type 1 and type 2 115
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 109
A new application for capillaroscopy: the study of dorsal surfaces of the hands in HHT 108
DHPLC-based mutation analysis of ENG and ALK-1 genes in HHT Italian population 106
13c-methacetin breath test: a new diagnostic tool for diagnosis of liver involvement in patients affected by hereditary hemorrhagic telangiectasia 105
Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: Echo-color-Doppler vs multislice computed tomography study 104
Hereditary Hemorrhagic Telangiectasia: a 15-year shorter life span 103
Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation 103
Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease 102
Orofacial hereditary haemorrhagic telangiectasia: High power diode laser in early and advanced lesion treatment 100
Hypogonadotropic hypogonadism associated with hereditary hemorrhagic telangiectasia 100
Hereditary Hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers 100
Neuroimmune activation in chronic heart failure 100
AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects 95
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 92
Effects of VEGF on phenotypic severity in children with hereditary hemorrhagic telangiectasia 92
Diet and myocardial infarction: a nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy 90
Abdominal obesity negatively influences key metrics of reverse cholesterol transport 90
Pulmonary Arteriovenous Malformations and Cerebral Abscess Recurrence in a Child With Hereditary Hemorrhagic Telangiectasia. 89
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia 89
Asymptomatic microhematuria: a spy of Hereditary Hemorrhagic Teleangiectasia (HHT)? 88
Homozygous familial hypercholesterolemia in a young woman with dual gene mutations of low-density lipoprotein receptor and proprotein convertase subtilisin/kexin type 9 88
Screening for children from families with Rendu-Osler-Weber disease: from geneticist to clinician 87
Pain and Frailty in Hospitalized Older Adults 85
Liver involvement in hereditary hemorrhagic telangiectasia: can breath test unmask impaired hepatic first-pass effect? 81
Hereditary hemorrhagic teleangiectasia: a 15-year shorter life span 78
Life expectancy in patients with hereditary haemorrhagic telangiectasia 78
Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab 77
Monocyte-to-HDL Ratio (MHR) Predicts Vitamin D Deficiency in Healthy and Metabolic Women: A Cross-Sectional Study in 1048 Subjects 77
Adipocyte fatty acid-binding protein 4 e iperlipemia familiare combinata 75
Improvement of the diagnostic accuracy of the liver shunts in hereditary hemorrhagic teleangiectasia 75
Capillaroscopic Patterns in Patients With HHT 74
null 72
Rare diseases in the elderly: a new perspective for the specialist in geriatrics 71
The lower is better”: genetic pitfalls of a paradigmatic approach for dyslipidemia 69
Clinical features of eng- and alk1- mutation carriers 66
What changed in the Italian internal medicine and geriatric wards during the lockdown 64
Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS) 63
Association of fT4 and TSH with insulin resistance in aged obese euthyroid people 62
Correlazione genotipo-fenotipo nella popolazione italiana affetta da Rendu-Osler-Weber (o Teleangiectasia Emorragica Ereditaria) 62
Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation 61
Studio longitudinale dell'evoluzione in età evolutiva delle malformazioni arterovenoso nella teleangiectasia emorragica ereditaria 61
Gli ammalati di Teleangiectasia Emorragica Ereditaria vivono in media 15 anni meno rispetto ai loro partners non affetti 61
Ultrasonographic analysis of HAVMS in a large cohort of hereditary hemorrhagic telangiectasia patients: definition of a new highly-accurate intrahepatic parameter 61
European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT) 61
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 61
HHT Oro-facial manifestations: histopathological and confocal laser scanning microscopy analysis 60
Involvement of the transforming growth factor beta in the pathogenesis of hereditary hemorrhagic telangiectasia 60
Hereditary haemorrhagic telangiectasia: study of hepatic vascular alterations with multi-detector row helical CT and reconstruction programs 59
Characterization of circulating endothelial cells in Hereditary Haemorrhagic Telangiectasia 58
COGNITIVE FUNCTIONS, MOOD STATE AND QUALITY OF LIFE IN PATIENTS WITH HHT 58
Rapida ed efficiente caratterizzazione di mutazioni in pazienti con Teleangiectasia Emorragica Ereditaria mediante DHPLC 58
Simplex index of insulin resistance in Hereditary Haemorrhagic Telangiectasia (HHT) patients. Preliminary data. 57
Il fenotipo hypertg-waist: impatto sul rischio cardiovascolare e sulla mortalità nella popolazione anziana. 56
Characterization of epidemiological distribution and outcome of COVID-19 in patients with hereditary hemorrhagic telangiectasia: a nationwide retrospective multi-centre study during first wave in Italy 56
Thyroid nodule malignancy is associated with increased non-invasive hepatic fibrosis scores in metabolic subjects 55
IDENTIFICATION AND VALIDATION OF THE CHRONO MED DIET SCORE: A SURVEY IN 9200 SUBJECTS 54
Improvement of the diagnostic accuracy of liver shunts in Hereditary Hemorrhagic Telangiectasia 54
Psycho-social effects regarding the job placement of hereditary hemorrhagic teleangectasia patients 53
Uso dell’angio-RM dinamica nello studio delle alterazioni parenchimali epatiche nei pazienti affetti da HHT: esperienza preliminare 53
Hyperhomocysteinemia is linked to MASLD 52
Multi-slice-ct vs dynamic time-resolved mr-angiography for evaluation of hepatic involvement in hereditary hemorragic telangiectasia 52
Diagnostic delay in rare diseases: the drama of a silent killer 51
Dynamic MR-angiography in the evaluation of hepatic involvement in hereditary hemorrhagic telangiectasia 50
Minimal portosystemic encephalopathy: A new nosological entity in patients with hereditary haemorrhagic telangiectasia 50
Longitudinal study of natural history of arteriovenous malformations in evolutionary age of Hereditary Haemorrhagic Telangiectasia 49
Efficacy of low-dose Bevacizumab in Hereditary Hemorrhagic Telangiectasia 49
Comment on: Atherogenic indices can predict atherosclerosis in patients with sarcoidosis 48
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 47
Manifestazioni cliniche in un'ampia coorte di pazienti pediatrici affetti da Teleangiectasia Emorragica Ereditaria 47
Dynamic 4D MR Angiography vs Multislice CT Angiography in the evaluation of vascular hepatic involvement in Hereditary Hemorragic Teleangiectasia (HHT) 46
Totale 9.368
Categoria #
all - tutte 47.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.253


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021632 0 0 0 0 0 77 174 49 83 115 68 66
2021/2022646 24 86 10 19 45 44 23 32 64 37 103 159
2022/20231.199 151 139 70 113 144 146 15 140 199 6 50 26
2023/2024558 36 95 39 50 49 106 25 59 7 23 18 51
2024/20252.305 94 44 132 84 93 201 248 241 94 125 318 631
2025/20262.489 734 280 313 496 582 84 0 0 0 0 0 0
Totale 10.300